Financings in Brief: Nanogen
This article was originally published in The Gray Sheet
Executive Summary
Nanogen: Completes a $6.5 mil. round of venture capital financing by investors including Enterprise Partners, Kleiner Perkins Caufield & Byers, Birndorf Biotechnology, and the Sprout Group. San Diego-based Nanogen initially is focusing on developing its technology -- which it says combines chemistry, molecular biology, and microelectronics -- for use in DNA probe rapid panel tests. The company says the financing will fund research and development activities "for the next 12-18 months, by which time the company expects to have completed a prototype product"...